Coronavirus: Utah man joined Moderna’s COVID-19 vaccine phase three trial – Deseret News

Luke Hutchison, a 44-year-old computational biologist in Utah, is currently involved in the phase three trials for Moderna’s COVID-19 vaccine, and he recently reported his symptoms so far.

  • Hutchison told CNBC he got his first shot on Aug. 18. He felt a little “cruddy” for a few days with a low fever.
  • He got his second shot on Sept. 15. The vaccine hit harder, sending him to his bed with a 101-degree fever, shakes, chills, a headache and shortness of breath.
  • The spot where he got the shot on his arm felt like a “goose egg on my shoulder.”
  • Twelve hours later, he said he felt normal again.
  • He knew he’d experience some symptoms, but he didn’t realize they would be so severe and feel like “full on COVID-like symptoms.”

Hutchison said he joined the trial because he’s physically fit and believes in vaccines. He said he wanted to support Moderna because it’s using a new RNA-based approach, which develops vaccines a little quicker than other methods.

“I had a high degree of confidence it would work and I wanted to contribute to the solution,” Hutchinson told CNBC.

Good news about the vaccine

Earlier this week, multiple reports said Moderna’s coronavirus vaccine developed strong immune responses in both older and younger adults. Experts consider this a positive sign since vaccines often don’t work well in the elderly, as I wrote about for Deseret.com.

Moderna, Pfizer, AstraZeneca and Johnson & Johnson all have late-stage human trials in play for the vaccine.

Read the original article

Author: The Covid-19 Channel